[{"Assets_0_Q1_USD":128625000.0,"CommonStockSharesOutstanding_0_Q1_shares":13268530.0,"NetIncomeLoss_1_Q1_USD":2300000.0,"StockholdersEquity_0_Q1_USD":107183000.0,"EarningsPerShareBasic_1_Q1_USD":0.17,"EarningsPerShareDiluted_1_Q1_USD":0.17,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":13446000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13200000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170203"}]